| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | D-glucose:sodium symporter activity | 2.80e-07 | 7 | 41 | 3 | GO:0005412 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 6.48e-07 | 81 | 41 | 5 | GO:0015370 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 4.36e-06 | 119 | 41 | 5 | GO:0015294 | |
| GeneOntologyMolecularFunction | carbohydrate:monoatomic cation symporter activity | 5.36e-06 | 17 | 41 | 3 | GO:0005402 | |
| GeneOntologyMolecularFunction | symporter activity | 1.35e-05 | 150 | 41 | 5 | GO:0015293 | |
| GeneOntologyMolecularFunction | D-glucose transmembrane transporter activity | 1.79e-05 | 25 | 41 | 3 | GO:0055056 | |
| GeneOntologyMolecularFunction | hexose transmembrane transporter activity | 1.79e-05 | 25 | 41 | 3 | GO:0015149 | |
| GeneOntologyMolecularFunction | monosaccharide transmembrane transporter activity | 2.27e-05 | 27 | 41 | 3 | GO:0015145 | |
| GeneOntologyMolecularFunction | myo-inositol transmembrane transporter activity | 2.46e-05 | 4 | 41 | 2 | GO:0005365 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 2.54e-05 | 171 | 41 | 5 | GO:0015081 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 2.83e-05 | 29 | 41 | 3 | GO:0051119 | |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 8.72e-05 | 42 | 41 | 3 | GO:0015144 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 1.31e-04 | 758 | 41 | 8 | GO:0015318 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 1.78e-04 | 793 | 41 | 8 | GO:0015075 | |
| GeneOntologyMolecularFunction | polyol transmembrane transporter activity | 3.16e-04 | 13 | 41 | 2 | GO:0015166 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 3.35e-04 | 296 | 41 | 5 | GO:0015291 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 3.48e-04 | 465 | 41 | 6 | GO:0046873 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 3.62e-04 | 301 | 41 | 5 | GO:0022853 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 5.36e-04 | 1180 | 41 | 9 | GO:0022857 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated channel activity | 7.63e-04 | 20 | 41 | 2 | GO:0141147 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated chloride channel activity | 7.63e-04 | 20 | 41 | 2 | GO:0005229 | |
| GeneOntologyMolecularFunction | transporter activity | 1.01e-03 | 1289 | 41 | 9 | GO:0005215 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 1.01e-03 | 23 | 41 | 2 | GO:0005283 | |
| GeneOntologyMolecularFunction | phospholipid scramblase activity | 1.01e-03 | 23 | 41 | 2 | GO:0017128 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase binding | 1.10e-03 | 24 | 41 | 2 | GO:0120283 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 1.61e-03 | 29 | 41 | 2 | GO:0005416 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 1.65e-03 | 627 | 41 | 6 | GO:0022890 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 2.15e-03 | 125 | 41 | 3 | GO:0015108 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 2.20e-03 | 664 | 41 | 6 | GO:0008324 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 2.34e-03 | 35 | 41 | 2 | GO:0005343 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 2.81e-03 | 477 | 41 | 5 | GO:0022804 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase inhibitor activity | 3.21e-03 | 41 | 41 | 2 | GO:0030291 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 3.66e-03 | 151 | 41 | 3 | GO:0008509 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 4.73e-03 | 50 | 41 | 2 | GO:0099095 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 4.92e-03 | 51 | 41 | 2 | GO:0140303 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 5.18e-03 | 171 | 41 | 3 | GO:0015103 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 6.93e-03 | 190 | 41 | 3 | GO:0004252 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 8.76e-03 | 207 | 41 | 3 | GO:0008236 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 9.09e-03 | 70 | 41 | 2 | GO:1901618 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 9.35e-03 | 212 | 41 | 3 | GO:0017171 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 1.01e-02 | 74 | 41 | 2 | GO:0005548 | |
| GeneOntologyMolecularFunction | peptidase activity | 1.05e-02 | 654 | 41 | 5 | GO:0008233 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 1.15e-02 | 430 | 41 | 4 | GO:0004175 | |
| GeneOntologyMolecularFunction | protein kinase inhibitor activity | 1.20e-02 | 81 | 41 | 2 | GO:0004860 | |
| GeneOntologyMolecularFunction | kinase inhibitor activity | 1.35e-02 | 86 | 41 | 2 | GO:0019210 | |
| GeneOntologyMolecularFunction | chloride channel activity | 1.35e-02 | 86 | 41 | 2 | GO:0005254 | |
| GeneOntologyMolecularFunction | flavin adenine dinucleotide binding | 1.60e-02 | 94 | 41 | 2 | GO:0050660 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 1.62e-05 | 275 | 41 | 6 | GO:0006814 | |
| GeneOntologyBiologicalProcess | myo-inositol transport | 3.84e-05 | 5 | 41 | 2 | GO:0015798 | |
| GeneOntologyBiologicalProcess | calcium activated phospholipid scrambling | 3.84e-05 | 5 | 41 | 2 | GO:0061588 | |
| GeneOntologyBiologicalProcess | calcium activated phosphatidylcholine scrambling | 3.84e-05 | 5 | 41 | 2 | GO:0061590 | |
| GeneOntologyBiologicalProcess | calcium activated galactosylceramide scrambling | 3.84e-05 | 5 | 41 | 2 | GO:0061591 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid catabolic process | 1.94e-04 | 145 | 41 | 4 | GO:0072329 | |
| GeneOntologyBiologicalProcess | D-glucose transmembrane transport | 2.10e-04 | 148 | 41 | 4 | GO:1904659 | |
| GeneOntologyBiologicalProcess | hexose transmembrane transport | 2.26e-04 | 151 | 41 | 4 | GO:0008645 | |
| GeneOntologyBiologicalProcess | monosaccharide transmembrane transport | 2.44e-04 | 154 | 41 | 4 | GO:0015749 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC6A5 ANO4 SLC5A11 SLC5A9 SLC6A11 AKT1 CALCRL PKD2L2 ANO3 SLC5A1 | 2.78e-04 | 1374 | 41 | 10 | GO:0006811 |
| GeneOntologyBiologicalProcess | pentose metabolic process | 2.97e-04 | 13 | 41 | 2 | GO:0019321 | |
| GeneOntologyBiologicalProcess | carbohydrate transmembrane transport | 3.40e-04 | 168 | 41 | 4 | GO:0034219 | |
| MousePheno | supernumerary incisors | 1.82e-05 | 3 | 35 | 2 | MP:0006369 | |
| Domain | NA_SOLUT_SYMP_1 | 1.48e-06 | 11 | 40 | 3 | PS00456 | |
| Domain | NA_SOLUT_SYMP_2 | 1.98e-06 | 12 | 40 | 3 | PS00457 | |
| Domain | SSF | 1.98e-06 | 12 | 40 | 3 | PF00474 | |
| Domain | Na/solute_symporter | 1.98e-06 | 12 | 40 | 3 | IPR001734 | |
| Domain | NA_SOLUT_SYMP_3 | 1.98e-06 | 12 | 40 | 3 | PS50283 | |
| Domain | Anoct_dimer | 9.33e-05 | 7 | 40 | 2 | PF16178 | |
| Domain | Anoct_dimer | 9.33e-05 | 7 | 40 | 2 | IPR032394 | |
| Domain | Na/solute_symporter_CS | 1.24e-04 | 8 | 40 | 2 | IPR018212 | |
| Domain | TLV/ENV_coat_polyprotein | 1.24e-04 | 8 | 40 | 2 | IPR018154 | |
| Domain | Anoctamin | 1.99e-04 | 10 | 40 | 2 | PF04547 | |
| Domain | Anoctamin | 1.99e-04 | 10 | 40 | 2 | IPR007632 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 6.70e-04 | 18 | 40 | 2 | PS00754 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 7.47e-04 | 19 | 40 | 2 | PS50267 | |
| Domain | SNF | 7.47e-04 | 19 | 40 | 2 | PF00209 | |
| Domain | Na/ntran_symport | 7.47e-04 | 19 | 40 | 2 | IPR000175 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 7.47e-04 | 19 | 40 | 2 | PS00610 | |
| Domain | Alkaline_phosphatase_core | 2.00e-03 | 31 | 40 | 2 | IPR017850 | |
| Domain | Alkaline_Pase-like_a/b/a | 2.00e-03 | 31 | 40 | 2 | IPR017849 | |
| Domain | - | 2.00e-03 | 31 | 40 | 2 | 3.40.720.10 | |
| Domain | Pkinase_C | 2.84e-03 | 37 | 40 | 2 | IPR017892 | |
| Domain | LDLR_class-A_CS | 3.31e-03 | 40 | 40 | 2 | IPR023415 | |
| Domain | Pkinase_C | 3.65e-03 | 42 | 40 | 2 | PF00433 | |
| Domain | Ldl_recept_a | 4.18e-03 | 45 | 40 | 2 | PF00057 | |
| Domain | - | 4.36e-03 | 46 | 40 | 2 | 4.10.400.10 | |
| Domain | LDLRA_1 | 4.74e-03 | 48 | 40 | 2 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 4.94e-03 | 49 | 40 | 2 | IPR002172 | |
| Domain | LDLa | 4.94e-03 | 49 | 40 | 2 | SM00192 | |
| Domain | LDLRA_2 | 4.94e-03 | 49 | 40 | 2 | PS50068 | |
| Domain | AGC-kinase_C | 6.40e-03 | 56 | 40 | 2 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 6.40e-03 | 56 | 40 | 2 | PS51285 | |
| Domain | S_TK_X | 6.40e-03 | 56 | 40 | 2 | SM00133 | |
| Pathway | WP_NRF2_PATHWAY | 6.58e-07 | 141 | 32 | 6 | M39454 | |
| Pathway | WP_NUCLEAR_RECEPTORS_METAPATHWAY | 6.47e-05 | 314 | 32 | 6 | M39428 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 1.82e-04 | 238 | 32 | 5 | MM15076 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 2.25e-04 | 249 | 32 | 5 | M5988 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 36472923 | ||
| Pubmed | Discovery and characterization of spontaneous mouse models of craniofacial dysmorphology. | 1.99e-06 | 21 | 41 | 3 | 26234751 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 23149623 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 26100275 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 1702069 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 28503860 | ||
| Pubmed | PKC-eta mediates glioblastoma cell proliferation through the Akt and mTOR signaling pathways. | 4.06e-06 | 3 | 41 | 2 | 15489897 | |
| Pubmed | The Par6alpha/aPKC complex regulates Akt1 activity by phosphorylating Thr34 in the PH-domain. | 8.12e-06 | 4 | 41 | 2 | 17335965 | |
| Pubmed | Shh Plays an Inhibitory Role in Cusp Patterning by Regulation of Sostdc1. | 8.12e-06 | 4 | 41 | 2 | 30325689 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 12739008 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 24595108 | ||
| Pubmed | Identification and characterization of TMEM16E and TMEM16F genes in silico. | 2.03e-05 | 6 | 41 | 2 | 15067359 | |
| Pubmed | 2.47e-05 | 143 | 41 | 4 | 20424473 | ||
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 22038040 | ||
| Pubmed | 6.07e-05 | 10 | 41 | 2 | 11884598 | ||
| Pubmed | Anoctamin/TMEM16 family members are Ca2+-activated Cl- channels. | 6.07e-05 | 10 | 41 | 2 | 19015192 | |
| Pubmed | Calcium-dependent phospholipid scramblase activity of TMEM16 protein family members. | 6.07e-05 | 10 | 41 | 2 | 23532839 | |
| Pubmed | 6.07e-05 | 10 | 41 | 2 | 12970426 | ||
| Pubmed | 6.07e-05 | 10 | 41 | 2 | 24692353 | ||
| Pubmed | 8.88e-05 | 12 | 41 | 2 | 14557543 | ||
| Pubmed | 1.05e-04 | 13 | 41 | 2 | 12761849 | ||
| Pubmed | Lrp4 modulates extracellular integration of cell signaling pathways in development. | 1.22e-04 | 14 | 41 | 2 | 19116665 | |
| Pubmed | Lrp4/Wise regulates palatal rugae development through Turing-type reaction-diffusion mechanisms. | 1.41e-04 | 15 | 41 | 2 | 30235284 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | 1.68e-04 | 1016 | 41 | 7 | 19056867 | |
| Pubmed | Effect of expression alteration in flanking genes on phenotypes of St8sia2-deficient mice. | 2.05e-04 | 18 | 41 | 2 | 31541165 | |
| Pubmed | 2.05e-04 | 18 | 41 | 2 | 33514739 | ||
| Pubmed | The repertoire of solute carriers of family 6: identification of new human and rodent genes. | 2.81e-04 | 21 | 41 | 2 | 16125675 | |
| Pubmed | Signalling crosstalk in FGF2-mediated protection of endothelial cells from HIV-gp120. | 4.00e-04 | 25 | 41 | 2 | 15689238 | |
| Pubmed | 5.03e-04 | 28 | 41 | 2 | 32801337 | ||
| Pubmed | 5.78e-04 | 30 | 41 | 2 | 15880404 | ||
| Pubmed | 6.11e-04 | 330 | 41 | 4 | 21044950 | ||
| Pubmed | 7.43e-04 | 34 | 41 | 2 | 23293290 | ||
| Pubmed | 7.87e-04 | 35 | 41 | 2 | 30940800 | ||
| Pubmed | 7.87e-04 | 35 | 41 | 2 | 34108685 | ||
| Pubmed | 8.33e-04 | 36 | 41 | 2 | 12412008 | ||
| Pubmed | USP1 deubiquitinates Akt to inhibit PI3K-Akt-FoxO signaling in muscle during prolonged starvation. | 8.80e-04 | 37 | 41 | 2 | 32133736 | |
| Pubmed | 1.03e-03 | 40 | 41 | 2 | 36843585 | ||
| Pubmed | Endothelin-2 deficiency causes growth retardation, hypothermia, and emphysema in mice. | 1.08e-03 | 41 | 41 | 2 | 23676500 | |
| GeneFamily | Anoctamins | 8.89e-05 | 10 | 26 | 2 | 865 | |
| GeneFamily | Solute carriers | 2.19e-04 | 395 | 26 | 5 | 752 | |
| GeneFamily | Proteases, serine | 3.68e-03 | 63 | 26 | 2 | 738 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.51e-02 | 206 | 26 | 2 | 682 | |
| Coexpression | HALLMARK_ADIPOGENESIS | 1.30e-05 | 200 | 40 | 5 | M5905 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_SMG_BASAL_CELL | 2.26e-05 | 380 | 40 | 6 | M45714 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | 1.44e-04 | 1035 | 40 | 8 | M9898 | |
| Coexpression | BUSSLINGER_DUODENAL_LATE_IMMATURE_ENTEROCYTES | 1.52e-04 | 177 | 40 | 4 | M40028 | |
| Coexpression | GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_FUSION_GFP_DN | 1.52e-04 | 177 | 40 | 4 | M8794 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_SMG_CELL | 1.53e-04 | 775 | 40 | 7 | M45713 | |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_BCELL_DN | 2.07e-04 | 192 | 40 | 4 | M9987 | |
| Coexpression | GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_DN | 2.38e-04 | 199 | 40 | 4 | M4575 | |
| Coexpression | GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDC_DN | 2.38e-04 | 199 | 40 | 4 | M4059 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | 2.39e-04 | 1115 | 40 | 8 | M10371 | |
| Coexpression | GSE30083_SP2_VS_SP4_THYMOCYTE_DN | 2.42e-04 | 200 | 40 | 4 | M5035 | |
| Coexpression | GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_DN | 2.42e-04 | 200 | 40 | 4 | M7286 | |
| Coexpression | GSE22601_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN | 2.42e-04 | 200 | 40 | 4 | M6251 | |
| Coexpression | GSE3982_MAC_VS_BCELL_UP | 2.42e-04 | 200 | 40 | 4 | M5494 | |
| Coexpression | GSE20727_CTRL_VS_DNFB_ALLERGEN_TREATED_DC_UP | 2.42e-04 | 200 | 40 | 4 | M9254 | |
| Coexpression | GSE3982_CTRL_VS_LPS_48H_DC_DN | 2.42e-04 | 200 | 40 | 4 | M5377 | |
| Coexpression | GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_DN | 2.42e-04 | 200 | 40 | 4 | M4889 | |
| CoexpressionAtlas | kidney_adult_RenalCortexMixed_Std_top-relative-expression-ranked_500 | 1.27e-05 | 424 | 40 | 7 | gudmap_kidney_adult_RenalCortexMixed_Std_500 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.09e-05 | 304 | 40 | 6 | gudmap_kidney_adult_JuxtaGlom_Ren1_k4_1000 | |
| CoexpressionAtlas | kidney_adult_RenalCortexMixed_Std_top-relative-expression-ranked_1000 | 2.50e-05 | 861 | 40 | 9 | gudmap_kidney_adult_RenalCortexMixed_Std_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#1_top-relative-expression-ranked_200 | 5.40e-05 | 39 | 40 | 3 | gudmap_developingKidney_e15.5_Proximal Tubules_200_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_top-relative-expression-ranked_1000 | 8.97e-05 | 784 | 40 | 8 | gudmap_developingKidney_e15.5_early proxim tubul_1000 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_top-relative-expression-ranked_500 | 9.61e-05 | 400 | 40 | 6 | gudmap_kidney_adult_JuxtaGlom_Ren1_500 | |
| CoexpressionAtlas | kidney_adult_RenalCortexMixed_Std_k-means-cluster#2_top-relative-expression-ranked_500 | 9.84e-05 | 248 | 40 | 5 | gudmap_kidney_adult_RenalCortexMixed_Std_k2_500 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | 1.02e-04 | 799 | 40 | 8 | gudmap_kidney_adult_JuxtaGlom_Ren1_1000 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_top-relative-expression-ranked_500 | 1.04e-04 | 406 | 40 | 6 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_500 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.39e-04 | 267 | 40 | 5 | gudmap_developingKidney_e14.5 whole kidney - wildtype_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_top-relative-expression-ranked_200 | 1.84e-04 | 151 | 40 | 4 | gudmap_developingKidney_e14.5 whole kidney - wildtype_emap-6674_200 | |
| CoexpressionAtlas | kidney_adult_RenalCortexMixed_Std_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.64e-04 | 482 | 40 | 6 | gudmap_kidney_adult_RenalCortexMixed_Std_k1_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.09e-04 | 173 | 40 | 4 | gudmap_developingKidney_e15.5_early proxim tubul_1000_k4 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_k-means-cluster#1_top-relative-expression-ranked_500 | 3.16e-04 | 174 | 40 | 4 | gudmap_kidney_adult_JuxtaGlom_Ren1_k1_500 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.35e-07 | 184 | 40 | 5 | ed7a8e79e5723a5f5a03f542203d9e50bdef5f50 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.52e-07 | 185 | 40 | 5 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.69e-07 | 186 | 40 | 5 | bdd9d3a432aab46e733469b362f0064d35c1ac49 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.87e-07 | 187 | 40 | 5 | 9042bd0f57213a51503d9df2e4dce3209b7772d3 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.89e-07 | 197 | 40 | 5 | 2e3d64648a1e4f01b9256a96b94b8a640ee1824c | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.11e-07 | 198 | 40 | 5 | 8d629492d2199de8e036c19e9dacceb9c9e721a0 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.34e-07 | 199 | 40 | 5 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 9.57e-07 | 200 | 40 | 5 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Fam159b|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.37e-06 | 148 | 40 | 4 | 9205b26e0d042b342cc643cda0f4f3f8bb392d00 | |
| ToppCell | Control-B_intermediate-10|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.34e-05 | 162 | 40 | 4 | aa80452b972bb8ad3670ffaba4ce26fadb33b185 | |
| ToppCell | C_02|World / shred on cell type and cluster | 1.44e-05 | 165 | 40 | 4 | a456c2c9ffe8dc91e17cac84ba87b88e016f8e6d | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.51e-05 | 167 | 40 | 4 | 97d0fea1f41c1c00e36d9b5c4c1f0dd85087056f | |
| ToppCell | pdx-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.85e-05 | 176 | 40 | 4 | 1e21f80cf0e695ffdd63e4a72cf1e3fa41b60341 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-05 | 176 | 40 | 4 | 1595dbeee336a81e581325d63208ec6262664ee9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-05 | 177 | 40 | 4 | 2f81b26be89cc2fd8eafadaf7eae3c6ad6521462 | |
| ToppCell | 21-Trachea-Epithelial-Submucosal_gland|Trachea / Age, Tissue, Lineage and Cell class | 1.94e-05 | 178 | 40 | 4 | 3e406e38eea0d38dc25edecf703c4c89ec6a28e0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.98e-05 | 179 | 40 | 4 | d1ef7e1cb00336118e387b47f4f8120f53584391 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.98e-05 | 179 | 40 | 4 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | IIH-plasma|IIH / Condition, Cell_class and T cell subcluster | 2.07e-05 | 181 | 40 | 4 | 13d1f31bcbac21aea91de74f51eed549ec61003e | |
| ToppCell | IIH-plasma-|IIH / Condition, Cell_class and T cell subcluster | 2.07e-05 | 181 | 40 | 4 | 140ac43dc6b89396872f908c14c89278f6d982b2 | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.07e-05 | 181 | 40 | 4 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-05 | 183 | 40 | 4 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-05 | 183 | 40 | 4 | 85446581999cd66b171c4f69b7eb8b0bbbaa8617 | |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.16e-05 | 183 | 40 | 4 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-05 | 183 | 40 | 4 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-05 | 184 | 40 | 4 | 9434731f651820b05335085582960f08fbf895de | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.25e-05 | 185 | 40 | 4 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.30e-05 | 186 | 40 | 4 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 186 | 40 | 4 | a417e1e21313a7e05951038cdef5ac672a9f727c | |
| ToppCell | Differ-KC|World / shred by cell class for mouse tongue | 2.35e-05 | 187 | 40 | 4 | 08f70e5103c6dd96f439f0cceda878963d26850d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.45e-05 | 189 | 40 | 4 | 78cf414b98bcb19deb934409acddaad1cd51b67f | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.55e-05 | 191 | 40 | 4 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.60e-05 | 192 | 40 | 4 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|World / Lineage, Cell type, age group and donor | 2.60e-05 | 192 | 40 | 4 | 1e156bab5ecf64627890d2de9b27603d9a01f28d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.60e-05 | 192 | 40 | 4 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.66e-05 | 193 | 40 | 4 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-05 | 193 | 40 | 4 | 1f978e102a029a6beb10913052cd0a20c7253e8e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-05 | 194 | 40 | 4 | fa6d51f36a3dae8763a595c20892987ed454c0f0 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_3|Classical_Monocyte / Disease condition and Cell class | 2.82e-05 | 196 | 40 | 4 | 15397ec27167bb2fb6fec120b68bf38fc71b2670 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 2.82e-05 | 196 | 40 | 4 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.94e-05 | 198 | 40 | 4 | 8f25e8dff42bad8e779ca618bdb1cb1610667962 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.94e-05 | 198 | 40 | 4 | e3e0aa3ef20b2370f5b133048510677aaa562dfa | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-mature_enterocytic|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.94e-05 | 198 | 40 | 4 | 8fac96132663f54566136ef54b53684d31dfde32 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.94e-05 | 198 | 40 | 4 | c48b3f026b16d48b8eca9f74dc1e3f3f39a89322 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.94e-05 | 198 | 40 | 4 | 6e6af8fad09f8e48b3f2ce463d5773b6a69864d1 | |
| ToppCell | 5'-Adult-SmallIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.00e-05 | 199 | 40 | 4 | a5fffe381be1ba7d192b68d1d3937ce47663658e | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.00e-05 | 199 | 40 | 4 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.00e-05 | 199 | 40 | 4 | 01c2721bc82cd672e9477029b4a7ecc77e2f1b00 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 3.05e-05 | 200 | 40 | 4 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.05e-05 | 200 | 40 | 4 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.05e-05 | 200 | 40 | 4 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 3.05e-05 | 200 | 40 | 4 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 3.05e-05 | 200 | 40 | 4 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-1|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.96e-04 | 126 | 40 | 3 | 8b689886ce35ff798aea603cde9ccb0dc9d1fd03 | |
| ToppCell | droplet-Liver-Npc-21m-Epithelial-Hepatocyte_(Midlobular)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-04 | 143 | 40 | 3 | 0cd332c128710291a39957d3da22953352f5c382 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Myl1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.91e-04 | 144 | 40 | 3 | 0322fef818a963be00535d5f141f028d43de5c6a | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Myl1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.97e-04 | 145 | 40 | 3 | 590ba937c741ae67460f303eca88b1cd3ac87f64 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.09e-04 | 147 | 40 | 3 | 22d71cf92b957e5a8aa63b13157626d013d6752b | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Fam159b|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.21e-04 | 149 | 40 | 3 | 98ae408d2d0347865875ff8bbd89d359decea526 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lect1_Oxtr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.21e-04 | 149 | 40 | 3 | 10ffd0051fb027bbebc662ca602c80d89bbf99c6 | |
| ToppCell | TCGA-Uterus-Primary_Tumor-Uterine_Carcinoma-Uterine_Carcinosarcoma|TCGA-Uterus / Sample_Type by Project: Shred V9 | 3.34e-04 | 151 | 40 | 3 | 2810bfa01bd3016aeba29735eb4a9284792e8aac | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.47e-04 | 153 | 40 | 3 | 9c6fce56300ba5053efda59a438d63a808c497c0 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.68e-04 | 156 | 40 | 3 | 0f2147abcf31a26ee5b2f4d8c5d72232612a33f0 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 3.68e-04 | 156 | 40 | 3 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Kcne4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.68e-04 | 156 | 40 | 3 | 896e2d958be0a5c62fb6eebad2dfb7e1ce69f3ad | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.68e-04 | 156 | 40 | 3 | cb87f12443fdc5538b856f765fcbac9406044e10 | |
| ToppCell | Basal_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 3.82e-04 | 158 | 40 | 3 | dd069a822e9698e6dddc155d9a5b52383f7879d5 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Pld5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.89e-04 | 159 | 40 | 3 | a082e770fa757c4a1d3ed13d53f83297e36faf05 | |
| ToppCell | IPF-Epithelial-PNEC|IPF / Disease state, Lineage and Cell class | 3.89e-04 | 159 | 40 | 3 | adec82df944fe8699a69ca52534353bef100f2f9 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Cbln4_Fezf2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.96e-04 | 160 | 40 | 3 | d8241404d775f9a709abdf17988f36293fcf4c58 | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-04 | 160 | 40 | 3 | 67ee7a314d7d4d3ea206e0158083f36f6dd7e80b | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 3.96e-04 | 160 | 40 | 3 | 0d4880f85565d8c540c94a8f8109147b3029279a | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-04 | 160 | 40 | 3 | 759749f708c3a2b36692d42499f19aff937e592f | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic-erythroblast|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-04 | 160 | 40 | 3 | fc76337ad766c859db390ef8b6fb9caeaace3a56 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Kcne4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.03e-04 | 161 | 40 | 3 | be77e99faf653480c166305df3a4e93db76f0dcb | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-04 | 162 | 40 | 3 | 5428c9fdb816f564395ebb4520448e5f3a42b025 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.18e-04 | 163 | 40 | 3 | bb09e6ca3406eee0593d9a312db7e05934309dd2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.18e-04 | 163 | 40 | 3 | 4be3158f2a0ab460cfea8080a7370922910b5da9 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 4.25e-04 | 164 | 40 | 3 | 362c16ed7fb37bf16601fd5e059d3f3e2ed692b4 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-04 | 165 | 40 | 3 | 8741df8066a44c841752a99ad306d26ea68f5344 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.41e-04 | 166 | 40 | 3 | 5ba45407a47207ff01e4a3f9f5d91d8247fe9b6f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-04 | 166 | 40 | 3 | ec719368295133da2f7ff587c5329ed6db1dd56d | |
| ToppCell | normal-na-Lymphocytic_B-B_atypical-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.41e-04 | 166 | 40 | 3 | 30a180b67572c3f4fb3a291f271f855e1b20005e | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.41e-04 | 166 | 40 | 3 | 6bd5aa205b6e4b88ba9f8cd0999e2191d7d1d16c | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_pre-Lymphocytic-T|bone_marrow / Manually curated celltypes from each tissue | 4.41e-04 | 166 | 40 | 3 | 20f248d95c86eb52a1efe9abe73123fbe4206caf | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L6_SST_NPY_(Sst_Chodl)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.41e-04 | 166 | 40 | 3 | 1629f23e4a37b836b454b976ae2a15fec414f7c0 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.49e-04 | 167 | 40 | 3 | f1ce6e64ebede1f3ef36fe982f46919fd1f814dd | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.56e-04 | 168 | 40 | 3 | 3fb79aaa858057c82645a90bd139fc4f096323c7 | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 4.56e-04 | 168 | 40 | 3 | 968405ea56f7d001ef83ff9274610923c3b2d55d | |
| ToppCell | Int-URO-Lymphocyte-B-B_intermediate|Int-URO / Disease, Lineage and Cell Type | 4.56e-04 | 168 | 40 | 3 | 5b3fb1fc8fea810c6d4e6feb42c24fb57e8066de | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_mem-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.64e-04 | 169 | 40 | 3 | e3ec9468141b6456398dca17dd8eeaabd2462710 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-04 | 169 | 40 | 3 | 3ad534303b4b60a77d171e605a1ba2ef20b5e2a3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-04 | 169 | 40 | 3 | 29dca061864c86218ab73a86cf6e3c522472da47 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.72e-04 | 170 | 40 | 3 | 67415b098e8ba815b501e557192a9f2b10ee995a | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-04 | 170 | 40 | 3 | 71c52fadecc6b4bfe98692b266adaa1406f6d56d | |
| ToppCell | systemic_lupus_erythematosus-treated-Hematopoietic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.72e-04 | 170 | 40 | 3 | 9a18756e6721980d4b6c37bb52ddfe93ca79c5ab | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-04 | 170 | 40 | 3 | d7c9a604311974ff87ece43a0f8725a234d262f7 | |
| ToppCell | ileum|World / shred on tissue and cell subclass | 4.72e-04 | 170 | 40 | 3 | 9f1211bd4287620e19a59f21e6ecdca3e42e0260 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Chat_Htr1f|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.81e-04 | 171 | 40 | 3 | f9ae7964a3740f559431125c17c660549798cccc | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.81e-04 | 171 | 40 | 3 | f648789e6aefe508bb748401bf9b3cd830fb0ddf | |
| Disease | asparaginase-induced acute pancreatitis | 5.78e-05 | 9 | 38 | 2 | EFO_1001507 | |
| Disease | FEV change measurement, response to zileuton | 4.75e-04 | 25 | 38 | 2 | EFO_0005921, EFO_0007676 | |
| Disease | eyelid sagging measurement | 7.82e-04 | 32 | 38 | 2 | EFO_0009360 | |
| Disease | dentate gyrus volume measurement | 1.16e-03 | 39 | 38 | 2 | EFO_0010083 | |
| Disease | Obesity | 2.33e-03 | 205 | 38 | 3 | C0028754 | |
| Disease | hippocampal atrophy | 2.38e-03 | 56 | 38 | 2 | EFO_0005039 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YGRAVDWWGLGVVMY | 326 | P31749 | |
| YYGPATWAEDGMWGY | 491 | Q14264 | |
| LHGGWGYMWEYPIAK | 386 | P28330 | |
| GMLYNPFSGYWHWSE | 306 | Q9NZJ6 | |
| WGGDYWRLLTPGDYM | 656 | Q96SM3 | |
| WTLNYGGIALMWRGG | 351 | P52209 | |
| KIGLYFAWLGWYTGM | 346 | Q32M45 | |
| FAWLGWYTGMLFPAA | 351 | Q32M45 | |
| QKYYLTGGWSIDWPG | 796 | Q8TE60 | |
| KIGLYFAWLGWYTGM | 391 | Q9BYT9 | |
| FAWLGWYTGMLIPAA | 396 | Q9BYT9 | |
| MATAGNPWGWFLGYL | 1 | Q9Y5K2 | |
| YHDIMYPAWTFWEGG | 156 | Q8NBL1 | |
| LGMVASWGWYAGYTV | 66 | Q92604 | |
| SWGWYAGYTVMEWGE | 71 | Q92604 | |
| GGYYWSWIRQHPGKG | 51 | P0DP07 | |
| WYYGMSWGLRLYIPG | 201 | P61550 | |
| AKEGAWPWVVGLYYG | 791 | P98073 | |
| QGVWAALSGGWYYDP | 11 | Q96RV3 | |
| IWGWSYGGYVTSMVL | 626 | P27487 | |
| GFFMPYWLWGSQLGK | 26 | Q9Y693 | |
| PMYWGSTANYLGWAI | 141 | Q9UBM1 | |
| WGGMLVWYMALFYPE | 336 | P34913 | |
| GLLSWYGTYGFWYPK | 226 | Q8N6M3 | |
| GVWGPYFSAMVPGFW | 311 | Q96C11 | |
| GPGYWDQHYLSWSML | 341 | Q8WWB7 | |
| GNWKLLTGYPGCGYW | 436 | P15848 | |
| HLMWYYFLGWGFPLI | 251 | Q16602 | |
| WAYPWVLYGGYLWMG | 76 | Q8N813 | |
| YWNMMLRGYWGGPAF | 426 | Q9Y6N5 | |
| LSWLGIFWMTGGLYA | 236 | Q7L1I2 | |
| GSYRYPNWSMVLGWL | 706 | Q9Y345 | |
| YNRYGWWVGEMKGAI | 331 | O75563 | |
| GYFLAGRSMSWWPIG | 66 | Q2M3M2 | |
| KGYFLAGGDMVWWPV | 56 | Q8WWX8 | |
| GCWWGVMYGFKGVSP | 311 | P54922 | |
| YPAWGYGIGWLMALS | 546 | P48066 | |
| VLFPYGAQGNWMWLG | 21 | Q9UBV4 | |
| MEGPLLEGLYWDSWY | 91 | Q9NZM6 | |
| PNWIGGGYGTKYWSR | 111 | Q6X4U4 | |
| WGLPLMALGTAAYWA | 706 | Q8TEQ8 | |
| WPGFIFGMSILTLWY | 276 | P13866 | |
| YGPAVDWWAMGVLLY | 531 | P24723 | |
| VEPMGGYMYWTDWGA | 866 | O75096 | |
| DYNEWYKGLGWSPAG | 2171 | P20929 |